The Proteomics Platform is equipped with a state-of-the-art Q-TOF as well as an Orbitrap Eclipse Tribrid mass spectrometer equipped with a FAIMS module, the first-of-its-kind in Canada, enabling a cutting-edge tumor antigen discovery program for the development of new immunotherapeutic strategies against cancer.
The platform was recently funded with a Canada Foundation for Innovation grant and will be expanding toward a mass spectrometry-based multi-omics platform to foster services and collaborations across the community in the different research themes. The platform delivers high-quality results and provides expertise in planning, designing, execution and data analysis, making the omics field accessible.
Equipements
- Thermo Orbitrap Eclipse Tribrid- FAIMS module
- Agilent QTof 6456
Services
- Immunopeptidomics
- Discovery and targeted proteomics
- Metabolomics
- Lipidomics
Clientele
Academic, pharmaceutical or biotechnology industries interested in proteomics/metabolotmics analyses.
Training
Upcoming basic training in proteomics.
Financial partners
- Fondation Charles-Bruneau
- Grandir en santé Fund
- Canada Foundation for Innovation
- Fondation CHU Sainte-Justine
Team
Contact
Maxim Isabelle, Ph.D.
Mass Spectrometry Platform Manager
514-345-4931, ext. 7883
maxim.isabelle.hsj@ssss.gouv.qc.ca
Other
Valérie Villeneuve
Commun Platforms Manager
514 345-4931, ext. 2786
valerie.villeneuve.hsj@ssss.gouv.qc.ca
Étienne Caron, Ph.D.
Scientific Director
514-345-4931, ext. 5199
etienne.caron.hsj@ssss.gouv.qc.ca